Recommendations

96
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
coronary angioplasty: a serial intravascular ultrasound study.
Circulation 1996;94:35-43.
100. Currier JW, Faxon DP. Restenosis after percutaneous transluminal
coronary angioplasty: have we been aiming at the wrong target? J
Am Coll Cardiol 1995;25:516-20.
101. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical
and angiographic paradigms. Circulation 1993;88:1310-23.
102. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized
model of restenosis after conventional balloon angioplasty, stenting
and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
103. Blackshear JL, O’Callaghan WG, Califf RM. Medical approaches
to prevention of restenosis after coronary angioplasty. J Am Coll
Cardiol 1987;9:834-48.
104. Bresee SJ, Jacobs AK, Garber GR, et al. Prior restenosis predicts
restenosis after coronary angioplasty of a new significant narrowing.
Am J Cardiol 1991;68:1158-62.
105. Hirshfeld JWJ, Schwartz JS, Jugo R, et al. Restenosis after coronary
angioplasty: a multivariate statistical model to relate lesion
and procedure variables to restenosis. The M-HEART
Investigators. J Am Coll Cardiol 1991;18:647-56.
106. Al SJ, Berger PB, Holmes DR, Jr. Coronary artery stents. JAMA
2000;284:1828-36.
107. Continued benefit of coronary stenting versus balloon angioplasty:
one-year clinical follow-up of Benestent trial. Benestent Study
Group. J Am Coll Cardiol 1996;27:255-61.
108. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre
PA. A comparison of coronary-artery stenting with angioplasty for
isolated stenosis of the proximal left anterior descending coronary
artery. N Engl J Med 1997;336:817-22.
109. George CJ, Baim DS, Brinker JA, et al. One-year follow-up of the
Stent Restenosis (STRESS I) Study. Am J Cardiol 1998;81:860-5.
110. Rodriguez A, Ayala F, Bernardi V, et al. Optimal coronary balloon
angioplasty with provisional stenting versus primary stent
(OCBAS): immediate and long-term follow-up results. J Am Coll
Cardiol 1998;32:1351-7.
111. Randomised placebo-controlled and balloon-angioplasty-controlled
trial to assess safety of coronary stenting with use of
platelet glycoprotein-IIb/IIIa blockade. The EPISTENT
Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Lancet 1998;352:87-92.
112. Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical
benefits of coronary-artery stenting and blockade of platelet glycoprotein
IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition
in Stenting Investigators. N Engl J Med 1999;341:319-27.
113. Betriu A, Masotti M, Serra A, et al. Randomized comparison of
coronary stent implantation and balloon angioplasty in the treatment
of de novo coronary artery lesions (START): a four-year follow-up.
J Am Coll Cardiol 1999;34:1498-506.
114. Weaver WD, Reisman MA, Griffin JJ, et al. Optimum percutaneous
transluminal coronary angioplasty compared with routine
stent strategy trial (OPUS-1): a randomised trial. Lancet
2000;355:2199-203.
115. Deleted in press. See Ref 658.
116. Waksman R, White RL, Chan RC, et al. Intracoronary gammaradiation
therapy after angioplasty inhibits recurrence in patients
with in-stent restenosis. Circulation 2000 May 9;101 (18 ):2165 -
71 101:2165-71.
117. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy
to inhibit restenosis after coronary stenting. N Engl J Med
1997;336:1697-703.
118. Ellis SG, Roubin GS, King SB, III, et al. Angiographic and clinical
predictors of acute closure after native vessel coronary angioplasty.
Circulation 1988;77:372-9.
119. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic
and clinical determinants of procedural outcome with angioplasty
for multivessel coronary disease: implications for patient
selection. Multivessel Angioplasty Prognosis Study Group.
Circulation 1990;82:1193-202.
120. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL,
Giorgi LV. “High-risk” percutaneous transluminal coronary
angioplasty. Am J Cardiol 1988;61:33G-7G.
121. Gaul G, Hollman J, Simpfendorfer C, Franco I. Acute occlusion
in multiple lesion coronary angioplasty: frequency and management.
J Am Coll Cardiol 1989;13:283-8.
122. Ellis SG, Roubin GS, King SB, III, et al. In-hospital cardiac mortality
after acute closure after coronary angioplasty: analysis of
risk factors from 8,207 procedures. J Am Coll Cardiol 1988;11:
211-6.
123. Guidelines for percutaneous transluminal coronary angioplasty: a
report of the American College of Cardiology/American Heart
Association Task Force on Assessment of Diagnostic and
Therapeutic Cardiovascular Procedures (Committee on
Percutaneous Transluminal Coronary Angioplasty). J Am Coll
Cardiol 1993;22:2033-54.
124. de Feyter PJ, van den Brand M, Laarman GJ, et al. Acute coronary
artery occlusion during and after percutaneous transluminal
coronary angioplasty: frequency, prediction, clinical course,
management, and follow-up [published erratum appears in
Circulation 1991 Jul;84(1):446]. Circulation 1991;83:927-36.
125. Myler RK, Shaw RE, Stertzer SH, et al. Lesion morphology and
coronary angioplasty: current experience and analysis. J Am Coll
Cardiol 1992;19:1641-52.
126. Kastrati A, Schomig A, Elezi S, et al. Prognostic value of the
modified American College of Cardiology/American Heart Association
stenosis morphology classification for long-term angiographic
and clinical outcome after coronary stent placement.
Circulation 1999;100:1285-90.
127. Budde T, Haude M, Hopp HW, et al. A prognostic computer
model to individually predict post-procedural complications in
interventional cardiology: the INTERVENT Project. Eur Heart J
1999;20:354-63.
128. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic
value of elevated baseline C-reactive protein among established
markers of risk in percutaneous coronary intervention. Circulation
2001;104:992-7.
129. Harrell L, Schunkert H, Palacios IF. Risk predictors in patients
scheduled for percutaneous coronary revascularization. Catheter
Cardiovasc Interv 1999;48:253-60.
130. Singh M, Lennon RJ, Holmes DR, Jr., Bell MR, Rihal CS.
Correlates of procedural complications and a simple integer risk
score for percutaneous coronary intervention. J Am Coll Cardiol
2002;40:387-93.
131. Zaacks SM, Allen JE, Calvin JE, et al. Value of the American
College of Cardiology/American Heart Association stenosis morphology
classification for coronary interventions in the late
1990s. Am J Cardiol 1998;82:43-9.
132. Krone RJ, Shaw RE, Klein LW, et al. Evaluation of the American
College of Cardiology/American Heart Association and the
Society for Coronary Angiography and Interventions lesion classification
system in the current “stent era” of coronary interventions
(from the ACC-National Cardiovascular Data Registry). Am
J Cardiol 2003;92:389-94.
133. Krone RJ, Laskey WK, Johnson C, et al. A simplified lesion classification
for predicting success and complications of coronary
angioplasty. Registry Committee of the Society for Cardiac
Angiography and Intervention. Am J Cardiol 2000;85:1179-84.